Literature DB >> 17203587

Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.

Mário H G Faria1, Bronner P A Gonçalves, Régia M do S V do Patrocínio, Manoel O de Moraes-Filho, Silvia H B Rabenhorst.   

Abstract

Astrocytomas represent the most frequent primary tumors of the central nervous system. Recently, the determination of the proliferative index of astrocytic tumors by different methods has been proposed as a valuable tool for tumor grading and also as a prognostic marker. The aim of the present study was to evaluate the expression of cell proliferation-related proteins in human astrocytic tumors of different histopathological grades (WHO). An immunohistochemical study of the Ki-67, Topoisomerase IIalpha (Topo IIalpha) and c-MYC proteins using the avidin-biotin-peroxidase method was performed in 55 astrocytomas (13 grade I, 14 grade II, 7 grade III and 21 grade IV) and five samples of non-tumor brain tissue (control group). Ki-67, Topo IIalpha and c-MYC positive indices tended to increase according to malignant progression, were absent in non-tumor brain tissue and showed maximum values in high-grade astrocytomas (III and IV). A gradual increase in Ki-67 antigen expression was observed in agreement with mitotic index and histopathological classification. The same was not observed for Topo IIalpha and c-MYC. Ki-67 antigen detection in more than 8.0% of the tumor cells distinguished astrocytoma grade IV, while a labeling index between 1.5 and 8.0% characterized astrocytomas grade III and values below 1.5% discriminated low-grade tumors (I and II). These results indicate that Topo IIalpha and c-MYC expression is associated with cell proliferation in astrocytomas, although not in an exclusive way. Moreover, Ki-67 antigen was found to be the best marker of cellular proliferation, and its expression predicts the grade of astrocytic tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17203587     DOI: 10.1111/j.1440-1789.2006.00724.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  16 in total

1.  Intracranial spreading of a spinal anaplastic astrocytoma.

Authors:  Tanja Schlereth; Bao Khang Nguyen-Huu; Harald Müller; Clemens Sommer; Wibke Müller-Forell; Frauke Zipp
Journal:  J Neurol       Date:  2011-10-01       Impact factor: 4.849

2.  Expression and clinical significance of EGFL7 in malignant glioma.

Authors:  Chun-hai Huang; Xue-jun Li; Yi-zeng Zhou; Yong Luo; Cui Li; Xian-rui Yuan
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

3.  CDC25A mRNA levels significantly correlate with Ki-67 expression in human glioma samples.

Authors:  Yoji Yamashita; Isao Kasugai; Masami Sato; Nobuhiro Tanuma; Ikuro Sato; Miyuki Nomura; Katsumi Yamashita; Yukihiko Sonoda; Toshihiro Kumabe; Teiji Tominaga; Ryuichi Katakura; Hiroshi Shima
Journal:  J Neurooncol       Date:  2010-03-10       Impact factor: 4.130

4.  Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor.

Authors:  A Arivazhagan; Durairaj Mohan Kumar; Vinay Sagar; Irene Rosita Pia Patric; S Sridevi; Balaram Thota; Mallavarapu R Srividya; K Prasanna; K Thennarasu; Neelima Mondal; A S Hegde; B A Chandramouli; V Santosh; M R S Rao; P Kondaiah; K Somasundaram
Journal:  J Neurooncol       Date:  2011-11-19       Impact factor: 4.130

5.  MiR-106a is an independent prognostic marker in patients with glioblastoma.

Authors:  Shiguang Zhao; Guang Yang; Yulong Mu; Dayong Han; Chen Shi; Xin Chen; Yifan Deng; Daming Zhang; Lu Wang; Yaohua Liu; Xu Hou; Chunlei Wang; Jianing Wu; Huailei Liu; Ligang Wang; Guang Zhang; Jiping Qi; Xiang Fang; Changbin Shi; Jing Ai
Journal:  Neuro Oncol       Date:  2013-02-14       Impact factor: 12.300

6.  Mechanism of p27 upregulation induced by downregulation of cathepsin B and uPAR in glioma.

Authors:  Sreelatha Gopinath; Kiranmai Alapati; Rama Rao Malla; Christopher S Gondi; Sanjeeva Mohanam; Dzung H Dinh; Jasti S Rao
Journal:  Mol Oncol       Date:  2011-07-26       Impact factor: 6.603

7.  Intracranial dissemination from spinal cord anaplastic astrocytoma.

Authors:  Seong Man Jeong; Yong Gu Chung; Jang Bo Lee; Il Young Shin
Journal:  J Korean Neurosurg Soc       Date:  2010-01-31

8.  Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas.

Authors:  Cui-Jie Shao; Jun Fu; Hong-Liu Shi; Yong-Gao Mu; Zhong-Ping Chen
Journal:  J Neurooncol       Date:  2008-04-16       Impact factor: 4.130

9.  In pursuit of prognostic factors in children with pilocytic astrocytomas.

Authors:  Aline Paixão Becker; Ricardo Santos de Oliveira; Fabiano Pinto Saggioro; Luciano Neder; Leila Maria Cardão Chimelli; Hélio Rubens Machado
Journal:  Childs Nerv Syst       Date:  2009-10-13       Impact factor: 1.475

10.  cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.

Authors:  Yazmin Odia; Brent A Orr; W Robert Bell; Charles G Eberhart; Fausto J Rodriguez
Journal:  J Neurooncol       Date:  2013-08-11       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.